Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid

被引：3
|
作者：
Autore, Francesco [1 ]
Chiusolo, Patrizia [1 ,2 ]
Sora, Federica [1 ,2 ]
Giammarco, Sabrina [1 ]
Laurenti, Luca [1 ,2 ]
Innocenti, Idanna [1 ]
Metafuni, Elisabetta [1 ]
Piccirillo, Nicola [1 ,2 ]
Pagano, Livio [1 ,2 ]
Bacigalupo, Andrea [1 ,2 ]
Leone, Giuseppe [1 ,2 ]
Sica, Simona [1 ,2 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, UOC Ematol, Dipartimento Diagnost Immagini Radioterapia Oncol, Rome, Italy
[2] Univ Cattolica Sacro Cuore, UOC Ematol, Dipartimento Diagnost Immagini Radioterapia Oncol, Fdn Policlin Univ A Gemelli IRCCS,Ist Ematol, Rome, Italy
来源：
LEUKEMIA & LYMPHOMA | 2019年 / 60卷 / 05期
关键词：
RISK;
D O I：
10.1080/10428194.2018.1522436
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1328 / 1330
页数：3
相关论文
共 50 条
  • [31] Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care
    Iland, Harry J.
    Wei, Andrew
    Seymour, John F.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2014, 27 (01) : 39 - 52
  • [32] Optimizing treatment for elderly patients with acute promyelocytic leukemia: is it time to replace chemotherapy with all-trans retinoic acid and arsenic trioxide?
    Tsimberidou, Apostolia-Maria
    Kantarjian, Hagop
    Keating, Michael J.
    Estey, Elihu
    LEUKEMIA & LYMPHOMA, 2006, 47 (11) : 2282 - 2288
  • [33] Distinctive features associated with differentiation syndrome in acute promyelocytic leukemia in patients treated by all-trans retinoic acid and arsenic trioxide
    Cingelova, Silvia
    Mikuskova, Eva
    Demitrovicova, Ludmila
    Mikudova, Vanda
    Slobodova, Alica
    Spanikova, Jana
    Vasickova, Radka
    Urban, Denis
    Drgona, Lubos
    Oravcova, Iveta
    LEUKEMIA RESEARCH, 2024, 145
  • [34] Therapy of acute promyelocytic leukemia:: All-trans retinoic acid and beyond
    Tallman, MS
    LEUKEMIA, 1998, 12 : S37 - S40
  • [35] USE OF ALL-TRANS RETINOIC ACID IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
    HUANG, ME
    YE, YC
    CHEN, SR
    CHAI, JR
    LU, JX
    ZHOA, L
    GU, LJ
    WANG, ZY
    BLOOD, 1988, 72 (02) : 567 - 572
  • [36] All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia
    Masetti, Riccardo
    Vendemini, Francesca
    Zama, Daniele
    Biagi, Carlotta
    Gasperini, Pietro
    Pession, Andrea
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (09) : 1191 - 1204
  • [37] PHARMACOKINETICS OF ORAL ALL-TRANS RETINOIC ACID IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA
    LEFEBVRE, P
    THOMAS, G
    GOURMEL, B
    AGADIR, A
    CASTAIGNE, S
    DREUX, C
    DEGOS, L
    CHOMIENNE, C
    LEUKEMIA, 1991, 5 (12) : 1054 - 1058
  • [38] Pharmacokinetics of all-trans retinoic acid in acute promyelocytic leukemia patients on dialysis
    Takitani, K
    Nagai, K
    Kanbe, E
    Inoue, A
    Kawakami, C
    Kuno, T
    Tamai, H
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 74 (02) : 147 - 148
  • [39] All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy
    Incerpi, MH
    Miller, DA
    Posen, R
    Byrne, JD
    OBSTETRICS AND GYNECOLOGY, 1997, 89 (05): : 826 - 828
  • [40] All-trans retinoic acid and early mortality in acute promyelocytic leukemia
    Rashidi, Armin
    Goudar, Ranjit K.
    Sayedian, Farzaneh
    Vos, Jeffrey A.
    Goldin, Teresa A.
    Aguilera, Nadine S.
    Fisher, Stephen I.
    LEUKEMIA RESEARCH, 2013, 37 (10) : 1391 - 1392
12345